Mithra Pharmaceuticals SA (MITRA) - Medical Equipment - Deals and Alliances Profile
- GDME220680D
- Pages: 34
- October 2018
- Total Views:1230
- Region : Europe
- GlobalData
- Equity Research Report
Details
Summary
Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women's health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.
Mithra Pharmaceuticals SA (MITRA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Equipment, Deal Details 10
Partnerships 10
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Equity Offering 12
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA-Key Competitors 15
Mithra Pharmaceuticals SA-Key Employees 16
Mithra Pharmaceuticals SA-Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 25, 2018: Mithra announces 2018 half year results 18
Mar 02, 2018: Mithra Reports 2017 Annual Results 23
Sep 21, 2017: Mithra Announces 2017 Half Year Results 28
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 29
Corporate Communications 32
Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 32
Other Significant Developments 33
May 16, 2018: Mithra Announces Injectable Contract With MIDAS Pharma 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List Of Figure
List of Figures
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Mithra Pharmaceuticals SA, Medical Equipment, Key Facts, 2017 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA, Key Competitors 15
Mithra Pharmaceuticals SA, Key Employees 16
Mithra Pharmaceuticals SA, Subsidiaries 17
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Mithra Pharmaceuticals SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women's health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.
Mithra Pharmaceuticals SA (MITRA)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Equipment, Deal Details 10
Partnerships 10
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Equity Offering 12
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA-Key Competitors 15
Mithra Pharmaceuticals SA-Key Employees 16
Mithra Pharmaceuticals SA-Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 25, 2018: Mithra announces 2018 half year results 18
Mar 02, 2018: Mithra Reports 2017 Annual Results 23
Sep 21, 2017: Mithra Announces 2017 Half Year Results 28
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 29
Corporate Communications 32
Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 32
Other Significant Developments 33
May 16, 2018: Mithra Announces Injectable Contract With MIDAS Pharma 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34
List Of Figure
List of Figures
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List Of Table
List of Tables
Mithra Pharmaceuticals SA, Medical Equipment, Key Facts, 2017 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Mithra Pharmaceuticals SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Deals By Market, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Adamed Enters into Licensing Agreement with Mithra Pharma for Myring 10
Mayne Pharma Enters into Licensing Agreement with Mithra Pharma 11
Mithra Pharma Raises USD90 Million in Private Placement of Shares 12
Mithra Pharma Raises USD29 Million in Private Placement of Shares 14
Mithra Pharmaceuticals SA, Key Competitors 15
Mithra Pharmaceuticals SA, Key Employees 16
Mithra Pharmaceuticals SA, Subsidiaries 17
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Mithra Pharmaceuticals SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
: +91 9015378249
Related Reports
Page 86 | 
August 2022
Page 42 | July 2022
Page 42 | July 2022
Page 47 | July 2022
Page 44 | July 2022